<ul><li>Luxembourg-based Exobiosphere has raised €2M in a seed funding round led by Expansion Ventures.</li><li>The funds will be used to accelerate the development of Exobiosphere's Orbital High-Throughput Screener (OHTS) for drug discovery in space.</li><li>OHTS uses space conditions to improve disease modeling and generate valuable data for AI in drug discovery.</li><li>Exobiosphere aims to shorten R&D timelines and bring safer, more effective treatments to market through microgravity drug discovery.</li></ul>

Luxembourg’s Exobiosphere raises €2M to accelerate drug discovery in space; here’s why and how

Discover more